SEC Contract Filing

Filing Date: 2023-05-02

Document Content:
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>11
<FILENAME>ea177745ex10-9_compute.htm
<DESCRIPTION>CONTRIBUTION AGREEMENT, DATED AS OF MAY 2, 2023, BY AND BETWEEN COMPUTE HEALTH SPONSOR LLC AND ALLURION TECHNOLOGIES HOLDINGS, INC
<TEXT>
<HTML>
<HEAD>
 <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><I>Execution Version</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONTRIBUTION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">THIS CONTRIBUTION AGREEMENT
(this &ldquo;<U>Agreement</U>&rdquo;), dated as of May&nbsp;2, 2023, is entered into by and between Compute Health Sponsor LLC, a Delaware
limited liability company (the &ldquo;<U>Contributor</U>&rdquo;), and Compute Health Acquisition Corp., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, on February 9, 2023,
the Company, Compute Health Corp., a Delaware corporation and a direct, wholly-owned subsidiary of the Company (&ldquo;<U>Merger Sub I</U>&rdquo;),
Compute Health LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of the Company (&ldquo;<U>Merger Sub II</U>&rdquo;),
Allurion Technologies Holdings, Inc., a Delaware corporation (&ldquo;<U>Pubco</U>&rdquo;), and Allurion Technologies, Inc., a Delaware
corporation and the parent of Pubco (&ldquo;<U>Allurion</U>&rdquo;), entered into that certain Business Combination Agreement, as amended
by that certain Amendment No. 1 to the Business Combination Agreement, dated as of May 2, 2023 and entered into simultaneously with
the execution of this Agreement, by and among the Company, Merger Sub I, Merger Sub II, Pubco and Allurion (as may be further amended
or modified from time to time, the &ldquo;<U>Business Combination Agreement</U>&rdquo;), pursuant to which, among other transactions,
as part of the same overall transaction, (a) the Company is to merge with and into Pubco (the &ldquo;<U>CPUH Merger</U>&rdquo;), with
Pubco surviving as the publicly-listed company and sole owner of Merger Sub I and Merger Sub II, (b) thereafter, Merger Sub I is to merge
with and into Allurion, with Allurion surviving as a wholly-owned subsidiary of Pubco (the &ldquo;<U>Intermediate Merger</U>&rdquo;) and
(c) thereafter, Allurion is to merge with and into Merger Sub II, with Merger Sub II surviving as a wholly-owned subsidiary of Pubco (collectively
with the CPUH Merger and the Intermediate Merger, the &ldquo;<U>Mergers</U>&rdquo;), in each case on the terms and conditions set forth
therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, on February 9, 2023,
the Contributor entered into that certain Sponsor Support Agreement (the &ldquo;<U>Sponsor Support Agreement</U>&rdquo;) with the Company,
the independent directors of the Company (as holders of Class B Common Stock (as defined below)), Pubco and Allurion;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, as of the date hereof,
the Contributor holds 21,442,500 shares of Class B common stock, par value $0.0001, of the Company (the &ldquo;<U>Class B Common Stock</U>&rdquo;
and such shares, the &ldquo;<U>Sponsor Class B Shares</U>&rdquo;) and 12,833,333 warrants to purchase shares of Class A common stock,
$0.0001 par value, of the Company (the &ldquo;<U>Class A Common Stock</U>&rdquo;), purchased in a private placement contemporaneously
with the initial public offering of the Company (the &ldquo;<U>Sponsor Private Warrants</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Sponsor Support
Agreement provides that, among other things, the Contributor will, immediately prior to the consummation of the CPUH Merger, recapitalize
all of the Sponsor Class B Shares and Sponsor Private Warrants into 2,088,327 shares of Class A Common Stock (the &ldquo;<U>Sponsor Recapitalization</U>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, in connection with
the CPUH Merger, subject to the terms and conditions of the Business Combination Agreement, each share of Class A Common Stock issued
and outstanding as of immediately prior to the CPUH Merger (after giving effect to the CPUH Stockholder Redemption (as defined in the
Business Combination Agreement)) will be cancelled and converted into the right to receive 1.420455 shares of common stock, par value
$0.0001 per share, of Pubco (the &ldquo;<U>Pubco Common Stock</U>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; marg